Pharma News

Lonza, NeuroSense Strike Deal Focused on Exploring Biological Markers for Neurodegenerative Diseases

Collaboration aims to advance the development of treatments for multiple neurodegenerative conditions, including amyotrophic lateral sclerosis.

Source link
#Lonza #NeuroSense #Strike #Deal #Focused #Exploring #Biological #Markers #Neurodegenerative #Diseases

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *